Literature DB >> 9850257

The management of dislocated lens material after phacoemulsification.

D A Bessant1, P M Sullivan, G W Aylward.   

Abstract

PURPOSE: To determine the visual outcome, prognostic factors, and effect of timing of surgical intervention in patients with retained lens fragments after phacoemulsification.
METHODS: A retrospective review was carried out of the notes of 44 consecutive patients who suffered posterior dislocation of lens fragments during phacoemulsification, of whom 34 underwent vitrectomy.
RESULTS: The presence of severe uveitis at presentation was a significant predictor of a final visual acuity of less than 6/60 (p = 0.002). A raised intraocular pressure at presentation (> 29 mmHg) significantly increased the risk of chronic glaucoma (p = 0.0279), but there was no association between glaucoma and delay in vitrectomy. Patients operated on within 1 week of cataract surgery obtained a better visual outcome (64.7%) of patients achieved 6/12 or better visual acuity) than those operated on later than 1 week (41% obtained 6/12), but this difference did not reach statistical significance.
CONCLUSIONS: The trend towards a better visual outcome with early vitrectomy was not statistically significant. A large prospective trial is indicated to determine the optimum time for vitrectomy in these patients.

Entities:  

Mesh:

Year:  1998        PMID: 9850257     DOI: 10.1038/eye.1998.161

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  2 in total

1.  Medical malpractice claims related to cataract surgery complicated by retained lens fragments (an American Ophthalmological Society thesis).

Authors:  Judy E Kim; Paul Weber; Aniko Szabo
Journal:  Trans Am Ophthalmol Soc       Date:  2012-12

2.  Outcomes of Cataract Surgery Complicated by Retained Lens Fragments Requiring Pars Plana Vitrectomy.

Authors:  Weijie V Lin; Megan N Scott; Chosang Tendhar; Shazia F Ali; Zaina Al-Mohtaseb; Rizwan Shaikh; Christina Y Weng
Journal:  Clin Ophthalmol       Date:  2020-03-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.